carbostyril has been researched along with Musculoskeletal Pain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baraldi, PG; Borea, PA; Corciulo, C; Gessi, S; Merighi, S; Saponaro, G; Tabrizi, MA; Targa, M; Varani, K; Vincenzi, F | 1 |
1 other study(ies) available for carbostyril and Musculoskeletal Pain
Article | Year |
---|---|
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
Topics: Animals; Behavior, Animal; Chronic Pain; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Ganglia, Spinal; Humans; Hyperalgesia; Inflammation; Male; Mice; Motor Activity; Musculoskeletal Pain; NF-kappa B; Oxazines; Pain Measurement; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Rotarod Performance Test; Treatment Outcome | 2013 |